Literature DB >> 12794258

Fibromyalgia in systemic lupus erythematosus: prevalence and clinical implications.

Dan Buskila1, Joseph Press, Mahmoud Abu-Shakra.   

Abstract

Fibromyalgia (FM) is common in SLE patients, and is the source of many of the symptoms and much of the disability in these patients. The association of FM and SLE may pose diagnostic dilemmas. Fibromyalgia does not correlate with SLE disease activity, but the clinical features of FM in these patients may contribute to a misinterpretation of lupus activity. The recognition of the association between SLE and FM is relevant to every physician who treats lupus patients.

Entities:  

Mesh:

Year:  2003        PMID: 12794258     DOI: 10.1385/CRIAI:25:1:25

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  29 in total

1.  Is high titre ANA specific for connective tissue disease?

Authors:  J H Vaile; L Dyke; R Kherani; C Johnston; T Higgins; A S Russell
Journal:  Clin Exp Rheumatol       Date:  2000 Jul-Aug       Impact factor: 4.473

Review 2.  The concurrence of lupus and fibromyalgia: implications for diagnosis and management.

Authors:  R Bennett
Journal:  Lupus       Date:  1997       Impact factor: 2.911

3.  Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus.

Authors:  D Da Costa; P L Dobkin; M A Fitzcharles; P R Fortin; A Beaulieu; M Zummer; J L Senécal; J R Goulet; E Rich; D Choquette; A E Clarke
Journal:  J Rheumatol       Date:  2000-02       Impact factor: 4.666

4.  Absence of autoantibodies in primary fibromyalgia.

Authors:  A Bengtsson; J Ernerudh; M Vrethem; T Skogh
Journal:  J Rheumatol       Date:  1990-12       Impact factor: 4.666

5.  The 'rule out lupus' rheumatology consultation: clinical outcomes and perspectives.

Authors:  D J Wallace; E Schwartz; H Chi-Lin; J B Peter
Journal:  J Clin Rheumatol       Date:  1995-06       Impact factor: 3.517

6.  Fibromyalgia in Indian patients with SLE.

Authors:  R Handa; P Aggarwal; J P Wali; N Wig; S N Dwivedi
Journal:  Lupus       Date:  1998       Impact factor: 2.911

7.  Antinuclear antibodies and connective tissue disease features in fibromyalgia syndrome: a controlled study.

Authors:  M B Yunus; F X Hussey; J C Aldag
Journal:  J Rheumatol       Date:  1993-09       Impact factor: 4.666

8.  Tender shins and steroid therapy.

Authors:  H A Smythe; D Lee; P Rush; D Buskila
Journal:  J Rheumatol       Date:  1991-10       Impact factor: 4.666

9.  A prospective long-term study of fibromyalgia syndrome.

Authors:  M Kennedy; D T Felson
Journal:  Arthritis Rheum       Date:  1996-04

10.  Fibromyalgia syndrome and disease activity in systemic lupus erythematosus.

Authors:  E F Morand; M H Miller; S Whittingham; G O Littlejohn
Journal:  Lupus       Date:  1994-06       Impact factor: 2.911

View more
  16 in total

1.  Is it necessary to strictly diagnose fibromyalgia syndrome in patients with chronic widespread pain?

Authors:  Arzu Yagiz On; Dilek Aykanat; Funda Calis Atamaz; Can Eyigor; Hayriye Kocanogullari; Fahrettin Oksel
Journal:  Clin Rheumatol       Date:  2015-05-26       Impact factor: 2.980

2.  Manifestations of systemic lupus erythematosus.

Authors:  Manole Cojocaru; Inimioara Mihaela Cojocaru; Isabela Silosi; Camelia Doina Vrabie
Journal:  Maedica (Buchar)       Date:  2011-10

3.  The prevalence of fibromyalgia in patients with Behçet's disease and its relation with disease activity.

Authors:  Mehmet Melikoglu; Meltem Alkan Melikoglu
Journal:  Rheumatol Int       Date:  2012-09-28       Impact factor: 2.631

Review 4.  Quality-of-life measurements versus disease activity in systemic lupus erythematosus.

Authors:  Adnan N Kiani; Michelle Petri
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

5.  Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity.

Authors:  Sema Haliloglu; Ayse Carlioglu; Derya Akdeniz; Yasar Karaaslan; Ali Kosar
Journal:  Rheumatol Int       Date:  2014-03-04       Impact factor: 2.631

6.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II.

Authors:  Reva C Lawrence; David T Felson; Charles G Helmick; Lesley M Arnold; Hyon Choi; Richard A Deyo; Sherine Gabriel; Rosemarie Hirsch; Marc C Hochberg; Gene G Hunder; Joanne M Jordan; Jeffrey N Katz; Hilal Maradit Kremers; Frederick Wolfe
Journal:  Arthritis Rheum       Date:  2008-01

7.  Predictors of self-reported health-related quality of life in systemic lupus erythematosus.

Authors:  Adnan N Kiani; Vibeke Strand; Hong Fang; Jawali Jaranilla; Michelle Petri
Journal:  Rheumatology (Oxford)       Date:  2013-05-16       Impact factor: 7.580

8.  Is there a predisposition for the development of autoimmune diseases in patients with fibromyalgia? Retrospective analysis with long term follow-up.

Authors:  Ina Kötter; Daniela Neuscheler; Ilhan Günaydin; Dorothee Wernet; Reinhild Klein
Journal:  Rheumatol Int       Date:  2007-07-20       Impact factor: 2.631

9.  Feasibility, Validity, and Reliability of the 10-item Patient Reported Outcomes Measurement Information System Global Health Short Form in Outpatients with Systemic Lupus Erythematosus.

Authors:  Shanthini Kasturi; Jackie Szymonifka; Jayme C Burket; Jessica R Berman; Kyriakos A Kirou; Alana B Levine; Lisa R Sammaritano; Lisa A Mandl
Journal:  J Rheumatol       Date:  2018-02-01       Impact factor: 4.666

Review 10.  Developments in the scientific and clinical understanding of fibromyalgia.

Authors:  Dan Buskila
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.